Prognostic and predictive value of 16p12.1 and 16q22.1 copy number changes in human breast cancer

Cancer Genetics and Cytogenetics

Volumn 198, Issue 1, 2010, Pages 52-61

  Downing, Tricia E ^a   Oktay, Maja H ^a   Fazzari, Melissa J ^a   Montagna, Cristina ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA;

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER RISK; CANCER STAGING; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME DELETION; CLINICAL EVALUATION; CONTROLLED STUDY; COPY NUMBER VARIATION; CORRELATIONAL STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MAPPING; GENE MUTATION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MALE; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TISSUE MICROARRAY; BREAST TUMOR; CHROMOSOME 16; GENETICS; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 16; DNA COPY NUMBER VARIATIONS; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS;

EID: 77950362656     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.12.007     Document Type: Article

References (34)

1. Stange D.E., Radlwimmer B., Schubert F., Traub F., Pich A., Toedt G., Mendrzyk F., Lehmann U., Eils R., Kreipe H., Lichter P. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer. Clin Cancer Res 2006, 12:345-352.
2. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., et al. Initial sequencing and analysis of the human genome [Erratum in: Nature 2001;412:565]. Nature 2001, 409:860-921.
3. Jang W., Yonescu R., Knutsen T., Brown T., Reppert T., Sirotkin K., Schuler G.D., Ried T., Kirsch I.R. Linking the human cytogenetic map with nucleotide sequence: the CCAP clone set. Cancer Genet Cytogenet 2006, 168:89-97.
4. Chin K., DeVries S., Fridlyand J., Spellman P.T., Roydasgupta R., Kuo W.L., Lapuk A., Neve R.M., Qian Z., Ryder T., Chen F., Feiler H., Tokuyasu T., Kingsley C., Dairkee S., Meng Z., Chew K., Pinkel D., Jain A., Ljung B.M., Esserman L., Albertson D.G., Waldman F.M., Gray J.W. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006, 10:529-541.
5. Fridlyand J., Snijders A.M., Ylstra B., Li H., Olshen A., Segraves R., Dairkee S., Tokuyasu T., Ljung B.M., Jain A.N., McLennan J., Ziegler J., Chin K., Devries S., Feiler H., Gray J.W., Waldman F., Pinkel D., Albertson D.G. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 2006, 6:96.
6. Bergamaschi A., Kim Y.H., Wang P., Sørlie T., Hernandez-Boussard T., Lonning P.E., Tibshirani R., Børresen-Dale A.L., Pollack J.R. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer 2006, 45:1033-1040.
7. Tirkkonen M., Tanner M., Karhu R., Kallioniemi A., Isola J., Kallioniemi O.P. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 1998, 21:177-184.
8. Montagna C., Lyu M.S., Hunter K., Lukes L., Lowther W., Reppert T., Hissong B., Weaver Z., Ried T. The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res 2003, 63:2179-2187.
9. Kim M., Gans J.D., Nogueira C., Wang A., Paik J.H., Feng B., Brennan C., Hahn W.C., Cordon-Cardo C., Wagner S.N., Flotte T.J., Duncan L.M., Granter S.R., Chin L. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 2006, 125:1269-1281.
10. Zender L., Spector M.S., Xue W., Flemming P., Cordon-Cardo C., Silke J., Fan S.T., Luk J.M., Wigler M., Hannon G.J., Mu D., Lucito R., Powers S., Lowe S.W. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006, 125:1253-1267.
11. Maser R.S., Choudhury B., Campbell P.J., Feng B., Wong K.K., Protopopov A., O'Neil J., Gutierrez A., Ivanova E., Perna I., Lin E., Mani V., Jiang S., McNamara K., Zaghlul S., Edkins S., Stevens C., Brennan C., Martin E.S., Wiedemeyer R., Kabbarah O., Nogueira C., Histen G., Aster J., Mansour M., Duke V., Foroni L., Fielding A.K., Goldstone A.H., Rowe J.M., Wang Y.A., Look A.T., Stratton M.R., Chin L., Futreal P.A., DePinho R.A. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 2007, 447:966-971.
12. Albertson D.G. Profiling breast cancer by array CGH. Breast Cancer Res Treat 2003, 78:289-298.
13. Isola J.J., Kallioniemi O.P., Chu L.W., Fuqua S.A., Hilsenbeck S.G., Osborne C.K., Waldman F.M. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 1995, 147:905-911.
14. Tanner M.M., Tirkkonen M., Kallioniemi A., Holli K., Collins C., Kowbel D., Gray J.W., Kallioniemi O.P., Isola J. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin Cancer Res 1995, 1:1455-1461.
15. Ried T., Just K.E., Holtgreve-Grez H., du Manoir S., Speicher M.R., Schröck E., Latham C., Blegen H., Zetterberg A., Cremer T., Auer G. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 1995, 55:5415-5423.
16. Hansen L.L., Yilmaz M., Overgaard J., Andersen J., Kruse T.A. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. Cancer Res 1998, 58:2166-2169.
17. Wennmalm K., Calza S., Ploner A., Hall P., Bjöhle J., Klaar S., Smeds J., Pawitan Y., Bergh J. Gene expression in 16q is associated with survival and differs between Sorlie breast cancer subtypes. Genes Chromosomes Cancer 2007, 46:87-97.
18. Nordgard S.H., Johansen F.E., Alnaes G.I., Bucher E., Syvänen A.C., Naume B., Børresen-Dale A.L., Kristensen V.N. Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients. Genes Chromosomes Cancer 2008, 47:680-696.
19. Hwang E.S., DeVries S., Chew K.L., Moore D.H., Kerlikowske K., Thor A., Ljung B.M., Waldman F.M. Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res 2004, 10:5160-5167.
20. Roylance R., Gorman P., Harris W., Liebmann R., Barnes D., Hanby A., Sheer D. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res 1999, 59:1433-1436.
21. Roohi J., Cammer M., Montagna C., Hatchwell E. An improved method for generating BAC DNA suitable for FISH. Cytogenet Genome Res 2008, 121:7-9.
22. Faggioli F., Sacco M.G., Susani L., Montagna C., Vezzoni P. Cell fusion is a physiological process in mouse liver. Hepatology 2008, 48:1655-1664.
23. Zeger S.L., Liang K.Y., Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988, 44:1049-1060. [Erratum in: Biometrics 1989;45:347].
24. Howell L.P., Gandour-Edwards R., O'Sullivan D. Application of the Scarff-Bloom-Richardson tumor grading system to fine-needle aspirates of the breast. Am J Clin Pathol 1994, 101:262-265.
25. Roylance R., Gorman P., Papior T., Wan Y.L., Ives M., Watson J.E., Collins C., Wortham N., Langford C., Fiegler H., Carter N., Gillett C., Sasieni P., Pinder S., Hanby A., Tomlinson I. A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH. Oncogene 2006, 25:6544-6553.
26. Korsching E., Packeisen J., Helms M.W., Kersting C., Voss R., van Diest P.J., Brandt B., van der Wall E., Boecker W., Bürger H. Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry. Br J Cancer 2004, 90:1422-1428.
27. Natrajan R., Lambros M.B., Geyer F.C., Marchio C., Tan D.S., Vatcheva R., Shiu K.K., Hungermann D., Rodriguez-Pinilla S.M., Palacios J., Ashworth A., Buerger H., Reis-Filho J.S. Loss of 16q in high grade breast cancer is associated with estrogen receptor status: evidence for progression in tumors with a luminal phenotype?. Genes Chromosomes Cancer 2009, 48:351-365.
28. Zheng L., Bidere N., Staudt D., Cubre A., Orenstein J., Chan F.K., Lenardo M. Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1. Mol Cell Biol 2006, 26:3505-3513.
29. Mercier I., Vuolo M., Jasmin J.F., Medina C.M., Williams M., Mariadason J.M., Qian H., Xue X., Pestell R.G., Lisanti M.P., Kitsis R.N. ARC (apoptosis repressor with caspase recruitment domain) is a novel marker of human colon cancer. Cell Cycle 2008, 7:1640-1647.
30. Foo R.S., Nam Y.J., Ostreicher M.J., Metzl M.D., Whelan R.S., Peng C.F., Ashton A.W., Fu W., Mani K., Chin S.F., Provenzano E., Ellis I., Figg N., Pinder S., Bennett M.R., Caldas C., Kitsis R.N. Regulation of p53 tetramerization and nuclear export by ARC. Proc Natl Acad Sci U S A 2007, 104:20826-20831.
31. Browne G.J., Proud C.G. A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin. Mol Cell Biol 2004, 24:2986-2997.
32. Albert M.L., Darnell J.C., Bender A., Francisco L.M., Bhardwaj N., Darnell R.B. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 1998, 4:1321-1324.
33. Snyder J.T., Alexander-Miller M.A., Berzofskyl J.A., Belyakov I.M. Molecular mechanisms and biological significance of CTL avidity. Curr HIV Res 2003, 1:287-294.
34. Green A.R., Krivinskas S., Young P., Rakha E.A., Paish E.C., Powe D.G., Ellis I.O. Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast. Breast Cancer Res Treat 2009, 113:59-66.